1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Pralsetinib: new trials by email Literature Review of Pralsetinib trials Research Report on Pralsetinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy Erlotinib, Trastuzumab, Trastuzumab emtansine - Breast Cancer, Gastrointestinal Cancer | Phase 2 | Unknown | Fondazione per la Medicina Personalizzata | 400 | 2020-10-07 | 2023-10-03 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Gastrointestinal Neoplasms (1)
Fondazione per la Medicina Personalizzata (1)
Italy (1)
Andrea Botticelli (1) · Paolo Marchetti (1)
2018 (1)